American Century Companies Inc Ideaya Biosciences, Inc. Transaction History

American Century Companies Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$34.37 - $43.46 $47,843 - $60,496	-1,392 Reduced 14.01%	8,541 $299,000
Q1 2024 May 14, 2024	SELL	$34.2 - $47.13 $26,539 - $36,572	-776 Reduced 7.25%	9,933 $435,000
Q4 2023 Feb 13, 2024	BUY	$24.59 - $35.83 $263,334 - $383,703	10,709 New	10,709 $381,000
Q3 2023 Nov 13, 2023	BUY	$21.07 - $29.77 $224,184 - $316,752	10,640 Added 36.67%	39,655 $1.07 Million
Q2 2023 Aug 14, 2023	BUY	$13.33 - $25.53 $159,853 - $306,155	11,992 Added 70.45%	29,015 $681,000
Q1 2023 May 11, 2023	BUY	$13.49 - $18.72 $68,947 - $95,677	5,111 Added 42.91%	17,023 $233,000
Q4 2022 Feb 13, 2023	BUY	$14.47 - $18.17 $172,366 - $216,441	11,912 New	11,912 $216,000

213

80.8M

69K

20K

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.07B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.